We are a highly qualified multidisciplinary team specialized in the fields of compounding pharmacy, software development and integration, design and automation, bringing together the expertise and engagement to develop automation solutions for the IV Room.
Kiro Grifols was founded in 2010 as a spin-off company from the Mondragon Corporation. Mondragon is the biggest business group in the Basque country. It is a cooperative that employs more than 80,000 people worldwide. Mondragon has expertise in industry, finance, retail and knowledge. In 2008 Mondragon Health , a separate division dedicated to developments in healthcare, was established.
Three MONDRAGON Corporation companies, Mondragon Assembly S.Coop. , Aurrenak S.Coop. and Loramendi S.Coop., together with the corporation’s institution Mondragon Innovation, supported the start up of KIRO Grifols.
On September 19, 2014 Grifols (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), the world’s third-largest manufacturer of plasma-derived biological medicines and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, acquired 50% of Kiro Grifols.
Download Press Release: Grifols acquires 50% of the equity of Kiro Grifols for 21 million euros.
Kiro Grifols is a technology company that specializes in the automation of equipment for the hospital sector. It concentrates on developing solutions to automate and control key points of hospital processes, and hospital pharmacy processes in particular, improving the safety of patients and health professionals alike, and delivering increased efficiency. It currently has some of the world’s most advanced technology in the hospital pharmacy sector: the KIRO Oncology System.
Grifols, through its Hospital division, with its experience, knowledge and international sales network, promotes the global marketing of the KIRO Oncology in the United States, Europe and other international Markets.